Clinical Trials for ImmunOs Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ImmunOs Therapeutics

Clinical Trials (1)

NCT05763004
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Mar 15, 2023 · Completed: May 31, 2025
1 condition2 sponsors5 locations